Cartesian Therapeutics (RNAC) Goodwill & Intangibles (2023 - 2025)
Historic Goodwill & Intangibles for Cartesian Therapeutics (RNAC) over the last 3 years, with Q3 2025 value amounting to $198.8 million.
- Cartesian Therapeutics' Goodwill & Intangibles changed 0.0% to $198.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $198.8 million for FY2024, which is 0.0% changed from last year.
- Per Cartesian Therapeutics' latest filing, its Goodwill & Intangibles stood at $198.8 million for Q3 2025, which was down 0.0% from $198.8 million recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Goodwill & Intangibles ranged from a high of $198.8 million in Q4 2023 and a low of $198.8 million during Q4 2023
- Over the past 3 years, Cartesian Therapeutics' median Goodwill & Intangibles value was $198.8 million (recorded in 2023), while the average stood at $198.8 million.
- Examining YoY changes over the last 5 years, Cartesian Therapeutics' Goodwill & Intangibles showed a top increase of 0.0% in 2024 and a maximum decrease of 0.0% in 2024.
- Over the past 3 years, Cartesian Therapeutics' Goodwill & Intangibles (Quarter) stood at $198.8 million in 2023, then changed by 0.0% to $198.8 million in 2024, then changed by 0.0% to $198.8 million in 2025.
- Its Goodwill & Intangibles was $198.8 million in Q3 2025, compared to $198.8 million in Q2 2025 and $198.8 million in Q1 2025.